In this video from Boston Atrial Fibrillation Symposium 2010, Professor John Camm discusses the two newest antiarrhythmic drugs, dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away. These antiarrhythmic (rhythm control) drugs help to put patients …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy discusses some of the new atrial fibrillation catheter ablation technologies and also talks about non-pharmacological approaches to stroke prevention in afib, such as the Watchman and Lariat suture. Dr. Reddy is the Director of Electrophysiology at Mount Sinai …
Read More
In part 2 of our video interview with Dr. Riccardo Cappato at Boston Atrial Fibrillation Symposium 2010, he discusses atrial fibrillation and its impact and treatment for athletes. Dr. Cappato is a cardiologist and Chief of the Arrhythmia and Electrophysiology Department at the Center of Clinical Arrhythmia and Electrophysiology at …
Read More
In part 1 of our video interview with Dr. Riccardo Cappato at Boston Atrial Fibrillation Symposium 2010, he discusses the results of the Second Worldwide Survey on AF Ablation. Dr. Cappato is a cardiologist and Chief of the Arrhythmia and Electrophysiology Department at the Center of Clinical Arrhythmia and Electrophysiology …
Read More
In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talks about gender differences in atrial fibrillation treatment and afib stroke risk in women. Dr. Russo is Director of Cardiac Ablation and Arrhythmia Services at Cooper University Hospital (New Jersey) and professor of medicine at Robert Wood …
Read More
One of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as …
Read More
New studies from the Mayo Clinic and the University of Alabama at Birmingham (UAB) show that African Americans are less likely to know they have atrial fibrillation or to be treated with anticoagulants to prevent afib-related strokes, and that stroke deaths are higher among blacks throughout the U.S. and southerners in eight "stroke belt" states. …
Read More
The Comprehensive Arrhythmia Research and Management Center (CARMA) at the University of Utah Heart Center in Salt Lake City, UT will present a free seminar on atrial fibrillation treatments on May 19th at which Dr. Nassir Marrouche and Mellanie True Hills, CEO of StopAfib.org, will speak. Learn more: Salt Lake City, UT Atrial Fibrillation Seminar …
Read More
The "AFib Educator" iPhone App and desktop and laptop widget was launched this morning by the AF Stat coalition. The purpose behind the tool is to help doctors communicate with atrial fibrillation patients, but patients can download it, too. Find out more and download it at: AFib Educator Smartphone App and Desktop Widget Offers Patient …
Read More
New research from Dr. Andrea Natale and colleagues on gender disparities in atrial fibrillation points out that women with afib are less likely to have catheter ablation treatment than men. When they do have atrial fibrillation catheter ablations, they tend to be older and sicker, meaning that they are more likely to have persistent or …
Read More